In Vivo Biodistribution of No-Carrier-Added 6-¹⁸F-Fluoro-3,4-Dihydroxy-l-Phenylalanine (¹⁸F-DOPA), Produced by a New Nucleophilic Substitution Approach, Compared with Carrier-Added ¹⁸F-DOPA, Prepared by Conventional Electrophilic Substitution

Willem-Jan Kuik, Philip H. Elsinga, Adrienne H. Brouwers et al.|Journal of Nuclear Medicine|2014

Cited by 66